fda hiv - Search News

News

HIV prevention drug lenacapavir approved by FDA

CBS News on MSN · 13h

HIV prevention drug lenacapavir approved by FDA as twice-yearly injection

Clinical trials showed 99.9% of participants who received the drug, called Yeztugo from company Gilead Sciences, remained HIV negative.

USA TODAY on MSN · 13h

FDA approves new twice-yearly HIV shot. What to know

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show prevents new infections.

UPI on MSN · 10h

FDA approves long-lasting HIV-prevention drug

The Food and Drug Administration has approved a new drug that could prevent HIV infections with just two shots every year and possibly eradicate the disease.

13hon MSN

FDA Approves a Twice-Yearly Shot to Prevent HIV

The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.

Fierce Pharma15h

FDA signs off on Gilead’s landmark long-acting PrEP med, signaling new era in HIV prevention

With the FDA’s much-anticipated nod for Gilead Sciences’ long-acting HIV pre-exposure prophylaxis (PrEP) injection Yeztugo ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results